StocksDeepDive
Snapshot · Russell 3000 · generated 2026-10-15 21:34 UTC

ELV — Elevance Health, Inc.

EXPENSIVE (MOS -11.0%) · Quality 59/100

Price
428.27
Intrinsic value
385.69
Margin of safety
-11.0%
Implied growth (reverse DCF)
+10.5%
model assumes +8.6%
Value Score
17.4
Quality
59
Psychology
-19.7
Discovery
17.7
price/volume attention only
Moat score
n/a
erosion: none

Value Score: bottom 20% of Russell 3000 · Quality: bottom 34%

Dividend: 6.87/share (TTM) · yield 1.6% · payout 30%

Open the interactive Deep Dive for ELV →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ELV - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ELV undervalued?

As of 2026-10-15, ELV trades at 428.27 against a computed intrinsic value of 385.69 (-11.0% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Elevance Health, Inc.'s Value Score?

Elevance Health, Inc.'s Value Score is 17.4 as of 2026-10-15 - it combines value, quality, crowd psychology and market attention into one number.

Does ELV pay a dividend?

Yes - ELV's trailing twelve-month dividend is 6.87/share, a yield of 1.6% at the current price (as of 2026-10-15).